Intuitive Surgical (ISRG) — insider trading
Health Care · NASDAQ
Intuitive Surgical (ISRG) has 28 reported SEC Form 4 insider transactions in our data, including 13 open-market sales among the most recent 28 (latest 2026-07-10).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion (derivative) | 1,910 | $0.00 | $0 | Form 4 |
| 2026-07-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Shares withheld for taxes / exercise cost | 947 | $411.55 | $389.7K | Form 4 |
| 2026-07-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion | 1,910 | $0.00 | $0 | Form 4 |
| 2026-06-12 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 25 | $414.13 | $10.4K | Form 4 |
| 2026-06-11 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $412.16 | $9.5K | Form 4 |
| 2026-06-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion (derivative) | 1,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Shares withheld for taxes / exercise cost | 674 | $426.61 | $287.5K | Form 4 |
| 2026-06-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion | 1,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | LOEB GARY | Officer (EVP & Chief Legal and Complian) | Open-market sale | 400 | $424.14 | $169.7K | Form 4 |
| 2026-06-10 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $424.14 | $9.8K | Form 4 |
| 2026-06-09 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $421.13 | $9.7K | Form 4 |
| 2026-06-08 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $420.12 | $9.7K | Form 4 |
| 2026-06-01 | Jeddi Iman | Officer (SVP & GM da Vinci Platforms &) | Option exercise / conversion (derivative) | 5,625 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Jeddi Iman | Officer (SVP & GM da Vinci Platforms &) | Open-market sale | 5,625 | $420.55 | $2.37M | Form 4 |
| 2026-06-01 | Jeddi Iman | Officer (SVP & GM da Vinci Platforms &) | Option exercise / conversion | 5,625 | $77.00 | $433.1K | Form 4 |
| 2026-05-22 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $439.80 | $7.9K | Form 4 |
| 2026-05-21 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $446.04 | $8.0K | Form 4 |
| 2026-05-20 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $440.38 | $7.9K | Form 4 |
| 2026-05-19 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $440.70 | $7.9K | Form 4 |
| 2026-05-18 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $422.47 | $7.6K | Form 4 |
| 2026-05-11 | LOEB GARY | Officer (EVP & Chief Legal and Complian) | Open-market sale | 400 | $446.95 | $178.8K | Form 4 |
| 2026-04-30 | GUTHART GARY S | Director | Grant / award / vesting (derivative) | 554 | $0.00 | $0 | Form 4 |
| 2026-04-30 | NACHTSHEIM JAMI K | Director | Grant / award / vesting (derivative) | 554 | $0.00 | $0 | Form 4 |
| 2026-04-30 | NACHTSHEIM JAMI K | Director | Option exercise / conversion (derivative) | 531 | $0.00 | $0 | Form 4 |
| 2026-04-30 | NACHTSHEIM JAMI K | Director | Option exercise / conversion | 531 | $0.00 | $0 | Form 4 |
| 2026-04-30 | Reed Monica P | Director | Grant / award / vesting (derivative) | 554 | $0.00 | $0 | Form 4 |
| 2026-04-30 | Reed Monica P | Director | Option exercise / conversion (derivative) | 531 | $0.00 | $0 | Form 4 |
| 2026-04-30 | Reed Monica P | Director | Option exercise / conversion | 531 | $0.00 | $0 | Form 4 |
Ask the chat about ISRG's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Intuitive Surgical (ISRG).
Last updated 2026-07-10 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.